Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Xiaoxi Lin

Showing results (281-290 of 292) with videos related to

Pageof 30
Sort By:
Journal of the American Academy of Dermatology|April 11, 2025
Genetic classification helps with precise sirolimus treatment in slow-flow vascular malformations: A prospective cohort studyHongyuan Liu, Yuxi Chen, Xuanfeng Chen, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|September 27, 2015
MicroRNA-346 functions as an oncogene in cutaneous squamous cell carcinomaBin Chen, Wenyan Pan, Xiaoxi Lin, et al.
Plos One|May 27, 2016
Hemoporfin Photodynamic Therapy for Port-Wine Stain: A Randomized Controlled TrialYi Zhao, Ping Tu, Guoyu Zhou, et al.
Journal of the American Academy of Dermatology|March 25, 2026
Artificial intelligence for diagnosis and treatment recommendation in infantile hemangioma: A retrospective multicenter diagnostic accuracy studyLimin Sun, Chenghong Jiang, Shengmiao Li, et al.
Radiology|December 14, 2017
Treatment of Early-stage Extracranial Arteriovenous Malformations with Intralesional Interstitial Bleomycin Injection: A Pilot StudyYunbo Jin, Yun Zou, Chen Hua, et al.
Applied and Environmental Microbiology|April 12, 2020
Ecological Importance of Cross-Feeding of the Intermediate Metabolite 1,2-Propanediol between Bacterial Gut SymbiontsChristopher C Cheng, Rebbeca M Duar, Xiaoxi Lin, et al.
BMC Medicine|July 3, 2023
Phase 1 dose-escalation study to evaluate the safety, tolerability, pharmacokinetics, and anti-tumor activity of FCN-159 in adults with neurofibromatosis type 1-related unresectable plexiform neurofibromasXiaojie Hu, Wenbin Li, Kang Zeng, et al.
Cell Reports|May 22, 2024
Critical roles of the miR-17∼92 family in thymocyte development, leukemogenesis, and autoimmunityKunyu Liao, Pengda Chen, Mengdi Zhang, et al.
Targeted Oncology|October 26, 2025
Phase 1 Study of Luvometinib Use in Pediatric Patients with Neurofibromatosis Type 1-Related Unresectable Plexiform NeurofibromasXiaojie Hu, Zhuli Wu, Jinhu Wang, et al.
Cell Research|September 11, 2019
Endothelial CDS2 deficiency causes VEGFA-mediated vascular regression and tumor inhibitionWencao Zhao, Le Cao, Hanru Ying, et al.
Pageof 30

Showing results (281-290 of 292) with videos related to

Sort By:
Pageof 30
Journal of the American Academy of Dermatology|April 11, 2025
Genetic classification helps with precise sirolimus treatment in slow-flow vascular malformations: A prospective cohort studyHongyuan Liu, Yuxi Chen, Xuanfeng Chen, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|September 27, 2015
MicroRNA-346 functions as an oncogene in cutaneous squamous cell carcinomaBin Chen, Wenyan Pan, Xiaoxi Lin, et al.
Plos One|May 27, 2016
Hemoporfin Photodynamic Therapy for Port-Wine Stain: A Randomized Controlled TrialYi Zhao, Ping Tu, Guoyu Zhou, et al.
Journal of the American Academy of Dermatology|March 25, 2026
Artificial intelligence for diagnosis and treatment recommendation in infantile hemangioma: A retrospective multicenter diagnostic accuracy studyLimin Sun, Chenghong Jiang, Shengmiao Li, et al.
Radiology|December 14, 2017
Treatment of Early-stage Extracranial Arteriovenous Malformations with Intralesional Interstitial Bleomycin Injection: A Pilot StudyYunbo Jin, Yun Zou, Chen Hua, et al.
Applied and Environmental Microbiology|April 12, 2020
Ecological Importance of Cross-Feeding of the Intermediate Metabolite 1,2-Propanediol between Bacterial Gut SymbiontsChristopher C Cheng, Rebbeca M Duar, Xiaoxi Lin, et al.
BMC Medicine|July 3, 2023
Phase 1 dose-escalation study to evaluate the safety, tolerability, pharmacokinetics, and anti-tumor activity of FCN-159 in adults with neurofibromatosis type 1-related unresectable plexiform neurofibromasXiaojie Hu, Wenbin Li, Kang Zeng, et al.
Cell Reports|May 22, 2024
Critical roles of the miR-17∼92 family in thymocyte development, leukemogenesis, and autoimmunityKunyu Liao, Pengda Chen, Mengdi Zhang, et al.
Targeted Oncology|October 26, 2025
Phase 1 Study of Luvometinib Use in Pediatric Patients with Neurofibromatosis Type 1-Related Unresectable Plexiform NeurofibromasXiaojie Hu, Zhuli Wu, Jinhu Wang, et al.
Cell Research|September 11, 2019
Endothelial CDS2 deficiency causes VEGFA-mediated vascular regression and tumor inhibitionWencao Zhao, Le Cao, Hanru Ying, et al.
Pageof 30